Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. E. Yagnenkova"'
Autor:
V. I. Ignatyeva, D. Yu. Ovsyannikov, A. E. Tsygankov, E. E. Yagnenkova, V. R. Amirova, M. M. Maryanyan, A. S. Mokrova
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 517-525 (2024)
Background. Respiratory syncytial virus (RSV) is a common virus causing lower respiratory tract infections (LRTI), including acute bronchiolitis and pneumonia, in children in the first 5 years of life.Objective: to estimate the annual socio-economic
Externí odkaz:
https://doaj.org/article/3a3e05f290134e63a64c801b3030222c
Autor:
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
Publikováno v:
Фармакоэкономика, Vol 13, Iss 3, Pp 225-239 (2020)
Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage of the pilot project and their coefficients of input intensity were not revised since then. The expansion of the range of genetically-engineered biologica
Externí odkaz:
https://doaj.org/article/02c332ca041f48a4bdd89718ab193121
Autor:
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov
Publikováno v:
Фармакоэкономика, Vol 14, Iss 2 (2021)
Background. The introduction of innovative drugs has significantly increased the treatment effectiveness in patients with relapsed/refractory multiple myeloma (RRMM), but the question of whether these expensive options can be financially secured rema
Externí odkaz:
https://doaj.org/article/5e3ab6bf218b4d07a9b2e4a646e4f6a2